Adaptimmune Therapeutics
ADAP
#9240
Rank
S$95.58 M
Marketcap
$0.36
Share price
4.45%
Change (1 day)
-76.85%
Change (1 year)

EPS for Adaptimmune Therapeutics (ADAP)

EPS in 2023 (TTM): -$0.74

According to Adaptimmune Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.70. In 2022 the company made an earnings per share (EPS) of -$1.33 a decrease over its 2021 EPS that were of -$1.33.

EPS history for Adaptimmune Therapeutics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.74-44.6%
2022-$1.33-0%
2021-$1.336.25%
2020-$1.26-27.27%
2019-$1.7329.41%
2018-$1.3320.09%
2017-$1.11-16.73%
2016-$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.41 1,247.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.23 76.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.15 638.20%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.37-153.08%๐Ÿ‡บ๐Ÿ‡ธ USA